RxDoctor Payments DataLook up a doctor →

John Vierling

Gastroenterology · Houston, TXNPI 1043390388

Payments from drug & device makers

$2,809,227in general payments, 2019–2025

Across 591 payments — averaging $4753.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intercept Pharmaceuticals, Inc.$845K
  • Gilead$518K
  • Novartis$320K
  • AbbVie$311K
  • E.r. Squibb & Sons, L.L.C.$270K
  • Pfizer$150K
  • plus $396K from 17 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Intercept Pharmaceuticals, Inc.197$844,714
Gilead156$518,473
Novartis12$320,269
AbbVie(2 entities)55$310,515
E.r. Squibb & Sons, L.L.C.14$269,589
Pfizer21$149,930
Merck24$75,121
Intercept Pharma Europe Ltd.15$71,062
Eiger Biopharmaceuticals, Inc.15$55,915
Mallinckrodt Enterprises LLC21$31,572
AstraZeneca10$26,536
Ipsen Biopharmaceuticals, Inc10$25,209
Mallinckrodt Hospital Products Inc.8$24,359
Ipsen Pharma SAS3$23,965
Eli Lilly4$22,663
GSK17$17,816
Takeda Pharmaceuticals U.S.A., Inc.2$9,996
Ipsen Innovation1$3,735
Orphalan Inc2$3,172
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC1$2,500
Amgen1$1,950
Fujifilm Wako Diagnostics U.S.A. Corporation1$126
Perspectum Diagnostics Ltd1$45

How this compares

$2,809,227 in reported general payments places this provider in the 95th percentile of 1,350 gastroenterology providers in Texas.

See all gastroenterology providers in Texas →

Other gastroenterology in Houston

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →